This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novo Nordisk A/s. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Jianhui Deng: Innovator in Biotechnology
Introduction
Jianhui Deng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of novel strains for peptide production. His innovative work has garnered attention in the scientific community.
Latest Patents
Jianhui Deng holds a patent for a novel non-pathogenic B BL21 strain. This strain comprises a deletion of the group II capsular gene cluster, which enhances its utility in the production of peptides. This invention represents a significant advancement in biotechnological applications.
Career Highlights
Deng is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role involves research and development in biotechnology, where he applies his expertise to create innovative solutions for health-related challenges.
Collaborations
Throughout his career, Jianhui has collaborated with notable colleagues, including Helle Fabricius Wöldike and Xin Zhao. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Jianhui Deng is a key figure in the biotechnology sector, with a focus on innovative solutions for peptide production. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile